Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

2.0K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
2.0K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

209
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
209
Pneumonia IV: Management01:28

Pneumonia IV: Management

324
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
324
Vaccinations01:51

Vaccinations

44.5K
Overview
44.5K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

236
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
236
Preventive Healthcare Services01:30

Preventive Healthcare Services

1.0K
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
1.0K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Is Immediate Lymphatic Reconstruction Cost-Effective for Breast Cancer Lymphedema?

Plastic and reconstructive surgery·2026
Same author

Mechanical venous thrombectomy may provide a cost-effective treatment option for patients with iliofemoral deep vein thrombosis.

Journal of vascular surgery. Venous and lymphatic disorders·2026
Same author

Integrating primary care for depression management during transition in sickle cell disease: A pre-post feasibility study.

British journal of haematology·2026
Same author

Cost-Effectiveness of Adjunctive Middle Meningeal Artery Embolization for Chronic Subdural Hematoma: Secondary Analysis of EMBOLISE.

AJNR. American journal of neuroradiology·2026
Same author

Impact of Serotype Uncertainty on Adult Pneumococcal Vaccine Options: A Value of Information Analysis.

American journal of preventive medicine·2026
Same author

Protection of metabolic-hemodynamic coupling by nimodipine in an animal model of cerebral small vessel disease.

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism·2026

相关实验视频

Updated: Jul 1, 2025

Experimental Human Pneumococcal Carriage
07:47

Experimental Human Pneumococcal Carriage

Published on: February 15, 2013

15.6K

50岁以上的肺炎球菌疫苗接种策略,以减少种族差异:美国社会视角成本效益分析

Shoroq M Altawalbeh1, Angela R Wateska2, Mary Patricia Nowalk3

  • 1Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; Department of Clinical Pharmacy, Jordan University of Science and Technology Faculty of Pharmacy, Irbid, Jordan.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
|March 10, 2024
PubMed
概括

将肺炎球菌疫苗 (PCV20) 扩展到所有50岁以上的人群是具有成本效益的,特别是在黑人人口中,以减少肺炎球菌疾病的种族差异. 与目前的建议相比,这种策略提供了更高的效率和更低的成本.

关键词:
经济效益性 经济效益性不同的差异,不平等的差异.肺炎球菌疾病的肺炎球菌病.社会视角 社会的视角

更多相关视频

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.1K
A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

2.5K

相关实验视频

Last Updated: Jul 1, 2025

Experimental Human Pneumococcal Carriage
07:47

Experimental Human Pneumococcal Carriage

Published on: February 15, 2013

15.6K
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.1K
A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

2.5K

科学领域:

  • 公共卫生 公共卫生
  • 卫生经济学 卫生经济学
  • 疫苗学 疫苗学 疫苗学

背景情况:

  • 在肺炎球菌疾病负担方面存在种族差异.
  • 肺炎球菌疫苗接种策略旨在减少疾病发生率和严重程度.
  • 对像PCV20这样的新疫苗进行评估对于公共卫生政策至关重要.

研究的目的:

  • 评估扩大肺炎球菌疫苗接种到所有50岁以上的人群的成本效益.
  • 为了比较20值肺炎球菌合疫苗 (PCV20) 和15值合疫苗/23值多糖疫苗 (PCV15/PPSV23) 的策略.
  • 从社会角度评估对种族差异的影响.

主要方法:

  • 一个终身马尔科夫模型被用于成本效益分析.
  • 对比50岁和65岁的人群的PCV20和PCV15/PPSV23,与当前的美国建议相比,没有接种疫苗.
  • 包括美国黑人和非黑人群体,包括直接和间接的社会成本.

主要成果:

  • 50岁和65岁的所有PCV20是黑人队伍中最具成本效益的策略.
  • 在非黑人群体中,PCV20在50岁和65岁时显示出有利的成本效益比率 ($62,083/QALY).
  • PCV15/PPSV23策略总是比PCV20.20更昂贵和更不有效.

结论:

  • 50岁和65岁的PCV20对美国普通人口来说是一个潜在的经济可行的战略.
  • 这一策略特别有利于减少肺炎球菌疾病负担和黑人群体的差异.
  • 这些发现支持将PCV20疫苗接种扩展到年轻年龄组.